PropertyValue
?:abstract
  • Autoantibodies in systemic sclerosis (SSc) can help stratify patients into more clinically-relevant subsets (reviewed in (1)). We read with interest the study of 804 adult SSc by Mecoli et al. (2), which represents the one of the largest study of anti-Th/To antibodies. The prevalence of 8.3% utilizing immunoprecipitation (IP) of four in-vitro transcribed and translated Th/To components (hPOP1/Rpp25/Rpp30/Rpp40) is consistent with previous studies (reviewed in (3)) (Figure 1).
?:creator
?:journal
  • Arthritis_rheumatol._(Malden._Online)
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Anti-Th/To antibodies: Association with lung disease and potential protection from systemic sclerosis related cancer?
?:type
?:who_covidence_id
  • #33079480
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/auwy1t3v>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/auwy1t3v>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all